eli lilly and company corporate center indianapolis indiana 46285 usa www com date july 21 2005 for release immediately refer to 317 276 2506 phil belt reports results second quarter sales increase 3 percent newer products contribute more than 620 million or 17 of total q2 nyse lly announced financial the highlights increased 668 billion alimta cialis non joint venture cymbalta forteo strattera symbyax xigris yentreve contributed 5 accounted compared with 10 in 2004 restructured arrangements its us wholesalers first as a result these during wholesaler inventory levels decreased approximately 30 reported net loss per share 252 0 23 respectively income 656 9 60 this is product liability charge 1 073 pretax 90
